ArticleMolecular cancer therapeutics2014

Differential and common DNA repair pathways for topoisomerase I- and II-targeted drugs in a genetic DT40 repair cell screen panel.

Yuko Maede et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.